Cite
HARVARD Citation
Vojdeman, F. et al. (n.d.). Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis. Leukemia & lymphoma. 54 (4), pp. 790-793. [Online].